Diamcor Announces Private Placement of up to CDN$3.0MStockhouseEach Unit will consist of one common share (a “Share”) of the Company and one-half of one common share purchase warrant (a “Warrant”). Each whole Warrant will entitle the holder thereof to purchase one Share at … The Agents will receive a cash fee … and more …read […]
Diamcor Announces Private Placement of up to CDN$3.0M – Stockhouse Read More »
Pieris Pharmaceuticals, Inc. Completes Private Placement, Raises $13.6MMarketwired (press release)In connection with the private placement, the Company issued warrants to acquire a combined total of up to approximately 542,361 shares of its common stock at an exercise price of $2.00 per share to Northland, Katalyst, Trout and their designees. …read more
ParkerVision Receives $7 Million Litigation Funding CommitmentGlobeNewswire (press release)Funder has also entered into a Warrant Subscription Agreement (“Warrant Agreement”) for the right to purchase up to 5,652,174 shares of the Company’s common stock. The purchase price of the warrants is $1.3 million and will be paid to the Company in … and more …read more
Interleukin Genetics Raises $10 Million in FinancingsBusiness Wire (press release)In connection with the loan agreement, the Company has issued to Horizon warrants to purchase a total of 2,492,523 shares of common stock at a per share exercise price of $0.1003. The lender warrants have a term of 10 years. The Company has agreed to …
Interleukin Genetics Raises $10 Million in Financings – Business Wire (press release) Read More »
The Canadian Bioceutical Corporation Announces Closing of $250000 Private …StockhouseTORONTO, ONTARIO / ACCESSWIRE / December 23, 2014 / The Canadian Bioceutical Corporation (“BCC”) (TSX VENTURE: BCC.V) announces today that it has received the Final Approval of the TSX Venture Exchange and has closed, effective today, the … …read more
The Canadian Bioceutical Corporation Announces Closing of $250000 Private … – Stockhouse Read More »
The Canadian Bioceutical Corporation Announces Closing of $250000 Private …Baystreet.caTORONTO, ONTARIO / ACCESSWIRE / December 23, 2014 / The Canadian Bioceutical Corporation (“BCC”) (TSX VENTURE: BCC.V) announces today that it has received the Final Approval of the TSX Venture Exchange and has closed, effective today, the … and more …read more
The Canadian Bioceutical Corporation Announces Closing of $250000 Private …MarketWatchDec 23, 2014 (ACCESSWIRE via COMTEX) — TORONTO, ONTARIO / ACCESSWIRE / December 23, 2014 / The Canadian Bioceutical Corporation (“BCC”) announces today that it has received the Final Approval of the TSX Venture Exchange and has closed … and more …read more
The Canadian Bioceutical Corporation Announces Closing of $250000 Private …MarketWatchDec 23, 2014 (ACCESSWIRE via COMTEX) — TORONTO, ONTARIO / ACCESSWIRE / December 23, 2014 / The Canadian Bioceutical Corporation (“BCC”) announces today that it has received the Final Approval of the TSX Venture Exchange and has closed … and more …read more
Vermillion (VRML) Announces $10.5M Private Placement; Ends ATM ProgramStreetInsider.com (subscription)In addition, the investors will receive warrants to purchase up to an aggregate of 4,166,659 shares of Vermillion common stock at an exercise price of $2.00 per share. The warrants become exercisable six months after the closing of the private … and more …read more
SeeThruEquity Initiates Research Coverage on Applied DNA Sciences, Inc. with …StockhouseThe common stock and warrants of APDN both trade on the NASDAQ under the symbols APDN and APDNW, respectively. On November 17th, APDN also announced the pricing of an underwritten public offering. The offering closed on November 20, 2014 … and more …read more